Drug Type Synthetic peptide |
Synonyms- |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseClinical |
First Approval Date- |
Regulation- |
Molecular FormulaC49H68N18O9S2.ClH |
InChIKeyMANLVWQYYRHWLE-GZRAWZNHSA-N |
CAS Registry2324799-41-7 |